Disease Management and Assessment Archives - Page 14 of 22

Antipsychotic-Induced Dopamine Supersensitivity Psychosis: Pharmacology, Criteria, & Therapy

Article March 28, 2018

Key Messages First-generation antipsychotics (FGAs) and second-generation antipsychotics (SGAs) provided major therapeutic advances for idiopathic and non-idiopathic psychotic disorders, but long-term D2 receptor blockade by these medications can lead to… Read More

Five Years Of Specialised Early Intervention Versus Two Years Of Specialised Early Intervention Followed By Three Years Of Standard Treatment For Patients With A First Episode Psychosis: Randomised, Superiority, Parallel Group Trial In Denmark (OPUS II)

Article March 28, 2018

Key Messages Long-term follow-up studies of specialized early intervention (SEI) programs following discontinuation have been contradictory. OPUS II was the first prolonged SEI study beyond three years. OPUS II reported… Read More

Addressing Diagnostic Complexities Of Bipolar Disorder (Distinguishing Bipolar Series Part 2)

On-Demand Webinar March 14, 2018

In the second part of a series on distinguishing bipolar disorder, Rif El-Mallakh, MD, and Mark Zimmerman, MD, build upon the science discussed during Part 1 of the series and… Read More

STEP-BD Hypotheses, Findings, & Clinical Implications With Dr. Joseph Goldberg

Interview March 7, 2018

In this interview, Jehan Marino, PharmD, BCPP, Senior Medical Science Liasion for Otsuka Pharmaceutical Development & Commercialization, Inc., speaks with Joseph Goldberg, MD, PsychU Bipolar Disorder Section Editor, Clinical Professor… Read More

Long-Acting Injectable Adherence & Sociodemographic Characteristics Of Use

Video February 14, 2018

In this interview, James McCreath, PhD, Vice President of Psychiatry & Behavioral Health at the Trinitas Regional Medical Center, discusses his co-authored publication “Long-Acting Injectable Antipsychotics For Schizophrenia: Sociodemographic Characteristics… Read More

Systematic Treatment Enhancement Program For Bipolar Disorder (STEP-BD): An Introduction To The Initial Findings

Video January 31, 2018

In this presentation, Julleah Johnson, PhD, Senior Medical Science Liaison, summarized initial findings from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD), a national public health initiative designed to… Read More

Burnout & Satisfaction With Work-Life Balance Among US Physicians Relative To The General US Population

Article January 8, 2018

Key Messages There has been no national study that has evaluated the rates of burnout among US physicians compared to US workers in other fields Burnout was measured using what… Read More

Tools To Assess & Address Medication Adherence In Patients With Serious Mental Illness

On-Demand Webinar December 13, 2017

Poor medication adherence presents a significant barrier to successful treatment and recovery in patients with serious mental illness and can negatively impact health outcomes and health care costs. While various… Read More

Mental Health & Metabolic Wellness Series: Focus On Hypertension

Video December 12, 2017

During this presentation, Steven Chen, PharmD, FASHP, FNAP, provided a brief overview of the role hypertension may play in outcomes in mental health. Key discussion points included: Prevalence and significance… Read More

Treating Insomnia May Lead To Improvements In Mental Health Symptoms

Article December 6, 2017

Background & Purpose Individuals with mental disorders often experience sleep difficulties, but traditionally, these have been considered symptoms of the illnesses. As a result, interventions for sleep may be given… Read More

Now Leaving PsychU

This link will take you outside of the PsychU community website

PsychU

Sorry, this content is no longer available.

Stay Connected: